We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$22.7B
AUM Growth
-$33.5M
(-0.15%)
Cap. Flow
-$2B
Cap. Flow
% of AUM
-8.79%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
2,101
New
297
Increased
583
Reduced
883
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$163M |
| 2 |
Merck
MRK
|
+$125M |
| 3 |
Royal Bank of Canada
RY
|
+$91.6M |
| 4 |
Johnson & Johnson
JNJ
|
+$89.1M |
| 5 |
Bank of Montreal
BMO
|
+$88.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$126M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 3 |
Johnson Controls International
JCI
|
+$91.5M |
| 4 |
Oracle
ORCL
|
+$90M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.94% |
| 2 | Consumer Discretionary | 13.96% |
| 3 | Healthcare | 13.37% |
| 4 | Financials | 11.87% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Affiliated Managers Group
AMG
$9.46B
| $7.18M | 0.03% |
48,168
+42,188
| +705% | +$5.52M |
|
527
Inspire Medical Systems
INSP
$1.42B
| $7.17M | 0.03% |
34,639
-9,871
| -22% | -$2.1M |
|
528
Bruker
BRKR
$9.2B
| $7.16M | 0.03% |
111,385
-45,976
| -29% | -$2.76M |
|
529
Knight Transportation
KNX
$11.8B
| $7.13M | 0.03% |
148,238
+5,719
| +4% | +$251K |
|
530
Amcor
AMCR
$20.6B
| $7.11M | 0.03% |
121,720
+49,711
| +69% | +$2.83M |
|
531
Rogers Communications
RCI
$17.7B
| $7.09M | 0.03% |
153,843
-58,022
| -27% | -$2.72M |
|
532
Lincoln National
LNC
$7.91B
| $7.08M | 0.03% |
113,660
-724,999
| -86% | -$40.1M |
|
533
Euronet Worldwide
EEFT
$3.02B
| $7.06M | 0.03% |
51,046
+32,660
| +178% | +$4.72M |
|
534
Exponent
EXPO
$2.98B
| $7.02M | 0.03% |
72,040
-19,718
| -21% | -$1.85M |
|
535
Zimmer Biomet
ZBH
$17.7B
| $6.98M | 0.03% |
44,934
+19,176
| +74% | +$2.97M |
|
536
Exelon
EXC
$48.6B
| $6.98M | 0.03% |
223,592
-803,632
| -78% | -$24.1M |
|
537
Emerson Electric
EMR
$82.9B
| $6.96M | 0.03% |
77,111
-158,094
| -67% | -$13.6M |
|
|
PRFT
538
DELISTED
Perficient Inc
PRFT
| $6.95M | 0.03% |
118,397
-237,841
| -67% | -$13.5M |
|
539
Energizer
ENR
$1.44B
| $6.95M | 0.03% |
146,453
+104,939
| +253% | +$4.83M |
|
540
Tyler Technologies
TYL
$12.2B
| $6.93M | 0.03% |
16,332
-8,268
| -34% | -$3.57M |
|
541
Thomson Reuters
TRI
$39.4B
| $6.92M | 0.03% |
74,990
-57,612
| -43% | -$5.13M |
|
542
Advanced Drainage Systems
WMS
$10.9B
| $6.9M | 0.03% |
66,704
+19,896
| +43% | +$1.94M |
|
543
Avis
CAR
$5.63B
| $6.88M | 0.03% |
94,830
+54,239
| +134% | +$2.8M |
|
544
Corcept Therapeutics
CORT
$10.2B
| $6.87M | 0.03% |
288,755
-37,575
| -12% | -$1M |
|
|
EPAY
545
DELISTED
Bottomline Technologies Inc
EPAY
| $6.83M | 0.03% |
151,036
-90,983
| -38% | -$4.38M |
|
546
CACI
CACI
$10.8B
| $6.82M | 0.03% |
27,656
-19,586
| -41% | -$4.69M |
|
547
Progyny
PGNY
$2.44B
| $6.82M | 0.03% |
153,160
-33,983
| -18% | -$1.59M |
|
548
Charles River Laboratories
CRL
$10.9B
| $6.81M | 0.03% |
23,489
-33,202
| -59% | -$9.23M |
|
549
Verisk Analytics
VRSK
$26.4B
| $6.8M | 0.03% |
38,513
-445
| -1% | -$81.5K |
|
550
Dolby
DLB
$4.72B
| $6.78M | 0.03% |
68,716
+27,702
| +68% | +$2.65M |
|
Similar funds
Man Group's Q1 2021 Portfolio in Review
As of Q1 2021, Man Group held 2,101 positions worth $22.7B, down 0.15% from $22.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group withdrew a net $2B in Q1 2021, closing 273 positions and reducing 883 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $49.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Man Group opened a new position in iShares Russell 2000 Value ETF worth $45.3M.
- Man Group's largest Q1 2021 buy was iShares Russell 2000 Value ETF: 283,817 shares worth $45.3M.
- Man Group added most to Intel in Q1 2021, an estimated $163M increase.
- Man Group's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $126M.
- Man Group fully exited IHS Markit Ltd. Common Shares in Q1 2021, selling an estimated $49.1M.
- Man Group's ten largest holdings make up 17% of its $22.7B portfolio in Q1 2021.
- Man Group opened 297 new positions and closed 273 in Q1 2021.
- Man Group's portfolio value fell 0.15% quarter-over-quarter to $22.7B.
Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.